New hope for brittle bones? first human test of osteoporosis drug begins
Disease control
ENROLLING_BY_INVITATION
This is the first-ever study in people for a new drug called LYN101. The main goal is to check its safety and how the body processes it. It will first be given as a single dose to healthy volunteers, and then as multiple doses to a small group of postmenopausal women with low bon…
Phase: PHASE1 • Sponsor: Shanghai TTM-Bio Technology Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC